Category: Covid-19 Vaccine

Page 257«..1020..256257258259..270280..»

Using AI in the arts to promote COVID-19 vaccines – University of Florida

April 12, 2022

Sure, it is fun to see an avatar simulate your body movements in real time, but the interactive augmented reality art installation making its way around campus has a serious aim: educating participants about how COVID-19 impacts health and encouraging vaccination.

The Covid Reflections installation isone of seven projects funded by the Arts for UF Vaccine Confidence Program, an initiative sponsored by UFs College of Arts Center for Arts in Medicine. Thecenter has previously partnered with the Centers for Disease Control and Prevention to increase COVID-19 vaccine confidence.

On Monday, the installation was set up outside the Reitz Union near a UF Health van offering free COVID-19 vaccines. As hoped, the avatar attracted groups of students who were giving it a workout. As of noon, about 30 people had tried it out.

The art installation consists of a large display connected to an iPhone that uses body tracking software to display a 3-D virtual avatar of a person standing in front of the screen. The avatar tracks the users movements and employs computer augmentation to present the impact of COVID-19 on the heart and lungs.

The installation also shows what happens to the avatar if vaccinated and ends with an FAQ section about COVID-19 vaccinations.

It was created by Ines Said, Austin Stansbury and Erica Del Hagen. Said is a software engineer who teaches in the Digital Worlds Institute; Stansbury and Hagen are graduate students in the institutes Masters in Digital ARts and Sciences (MiDAS) program.

The team wanted to explore how augmented reality could be used in a public health setting, Stansbury said. They used the Unity programming language, primarily designed for game development, to create an app that works on an iPhone, which Said describes as both innovative and really hard.

We thought it would be a novel way to provide information about COVID19 and connect with students in a way the media hasnt, Stansbury said.

The installation will be set up at the Plaza of the Americas from 9 a.m. to 3 p.m. on April 12 and April 18. The trio also will present the project at this months AI Symposium on April 14 and the Convergence Student Showcase set for April 18. They also plan to author a paper on using artificial reality in public displays to promote public health.

This event is in partnership with UF health officials to ensure that the information is accurate and up-to-date.

Natalie Rella, the Center for Arts in Medicine communications and marketing specialist, believes this project as well as the six others on arts and COVID-19 will result in more vaccinations in the community.

This is a cross-sector integration of arts and medicine and hearts and minds, she said. Maybe through this avenue, we can make an impact.

Visit link:

Using AI in the arts to promote COVID-19 vaccines - University of Florida

COVID-19 vaccination during pregnancy not associated with any observable birth defects on ultrasound – News-Medical.Net

April 12, 2022

In our latest interview, News Medical speaks to Dr. Rachel Ruderman, a fourth-year resident at Northwestern University Feinberg School of Medicine, about her current research, which reveals no detectable link on ultrasound scans between COVID-19 vaccination and birth defects.

My name is Rachel Ruderman. I am a 4thyear resident in obstetrics and gynecology at Northwestern University in Chicago. I love obstetrics -the changing physiology of pregnancy and how it impacts women and their children not only during pregnancy but after. Pregnancy can also expose significant future health risks and issues with social and economic support that really impact health.

Through the last two years of the pandemic, I have seen an amazing emergence of high-quality data and science on COVID in pregnancy and the development of lifesaving vaccines. Despite excellent evidence that COVID vaccines are safe and effective, many pregnant women have been hesitant to be vaccinated. Much of this stems back to pregnant people's initial exclusion from vaccine trials.

However, we now have a fund of research that supports the idea that the vaccine is safe and effective in pregnancy, while COVID during pregnancy can lead to worse maternal and fetal outcomes. Still - I noticed that a lot of my patients were hesitant to be vaccinated, and often cited their baby as the reason why. Thus, I wanted to look at whether getting the vaccine earlier in the pregnancy, during a key developmental time, as opposed to later in pregnancy or not at all, could be associated with an increased risk of birth defects.

Image Credit: Prostock-studio/Shutterstock

Birth defects are a large group of congenital abnormalities which include external structural defects (i.e. cleft lip) and internal structural defects(i.e. cardiac abnormalities). Major defects are extremely taxing to the neonate, the parents, and the healthcare system. For example, certain congenital cardiac anomalies require several surgeries, prolonged inpatient admissions, and high costs to the parents as well as the healthcare system.

Tons of research focuses on what we can tell our patients are safe and unsafe during pregnancy, especially during the critical period of organ development (the "Teratogenic Window") so we can prevent the physical, mental, social, and economic impacts of birth defects.

The study involved looking at patients who had a routine mid-pregnancy anatomy scan and documentation about vaccination status. If a vaccine was administered in pregnancy, we recorded at what point in pregnancy it was given. In Illinois, this is more easily done because of a state-wide database that records vaccinations and shares them with providers across different hospital systems (I-CARE [illinois.gov]). From there, we looked at the patient's demographics (age, number of pregnancies, self-reported race, and ethnicity), as well as other health issues like high blood pressure and diabetes.

With all this information, we were able to see if the timing of vaccination impacted anomalies discovered on these mid-trimester ultrasounds. We also looked at whether pre-existing conditions (like diabetes) or age impacted the presence of anomalies. We found no difference in the rate of anomalies between those vaccinated during the "Teratogenic Window" and those either vaccinated later in pregnancy or those not vaccinated at all. There was no increased risk after adjusting for those pre-existing conditions.

Image Credit: Keron art/Shutterstock

TheCDC has a database called the V-safe registry, which looks at outcomes from pregnant women who have received the vaccines. They found no difference in outcomes in those who got the vaccine compared to controls. However, people that got the COVID vaccine early on are different from those who declined vaccination, and our study gives more information on these different patients. We looked at patients who not only declined vaccination but also got vaccinated later in pregnancy and discovered the same outcomes.

We know that pregnant patients with COVID have an increased risk forICU admission and intubation, as well as anincreased risk for high blood pressure disorders of pregnancy, preterm birth, and needing a c-section. What we know now in addition is that the vaccines developed for the general population are safe and effective for pregnant patients and help dramatically decrease these risks. We also know that antibodies from the vaccine werehigher than the antibodies people received from a COVID infection.

I have seen firsthand the misinformation online and how it has made my patients skeptical of getting the vaccine during pregnancy. The more we can counter this dangerous messaging with real, high-quality data, the better and safer our patients and their babies will be. It's so important to break down this information so the general public can really understand for themselves what the evidence is and make decisions that can benefit them in the long run.

I have noticed that having conversations with my patients that are honest and open is the most helpful. I always ask people why they are hesitant or concerned, and then try to explain my recommendations using the significant amount of evidence we have on the Covid vaccine during pregnancy.I always check if my pregnant and postpartum patients are vaccinated and boosted. Talking with patients one on one and validating their concerns can go a long way.

Image Credit: eggeegg/Shutterstock

Next year I will be a Maternal Fetal Medicine fellow at the University of Chicago taking care of high-risk pregnancies (sick moms and babies). I plan to do research on the postpartum period and would love to look at the postpartum experiences of women who were vaccinated against COVID or infected with COVID during pregnancy.

I would always recommend checking out reputable sites like the CDC and WHO. There's a lot of great COVID information for patients on ACOG's website (the American College of Obstetricians and Gynecologists). There's a lot of misinformation online so it's important to make sure the sources you're accessing are legitimate!

Readers can find the full study at: https://news.northwestern.edu/stories/2022/03/covid-19-vaccine-not-associated-with-birth-defects/?fj=1

Rachel Ruderman is a native of Chicago. She attended the University of Michigan where she studied Global Health and received a Master of Public Health. She returned to Chicago for medical school and stayed for residency at Northwestern. During her tenure at Northwestern, she has published on issues of accessing quality postpartum care.

Rachel also developed awomen's health advocacy curriculum and established an infertility education program at Chicago's John H. Stroger Jr Hospital, a safety net hospital in the city. Next year she will be a Maternal Fetal Medicine fellow at the University of Chicago where she plans to do research on the postpartum period.

View original post here:

COVID-19 vaccination during pregnancy not associated with any observable birth defects on ultrasound - News-Medical.Net

How do COVID-19 vaccines work? | City News – Red and Black

April 12, 2022

When germs infiltrate our bodies, such as the virus that causes COVID-19, they assault and grow. The invasion causes an illness, which is known as an infection. To combat infection, our immune system employs a variety of strategies. Red blood cells provide oxygen to tissues and organs whereas white blood cells, often known as immune cells, combat illness.

When a person is infected with the virus that causes COVID-19 for the first time, it might take several days or weeks for their body to develop and employ all of the germ-fighting mechanisms needed to recover. The person's immune system recalls what it learned about how to defend the body against COVID-19 after the infection.

The body normally produces T-lymphocytes and B-lymphocytes types of white blood cells a few weeks following immunization. As a result, a person might become infected with the virus that causes COVID-19 either before or shortly after immunization and become ill as a result of the vaccine failing to give adequate protection.

The process of establishing immunity following vaccination can sometimes induce symptoms such as fever. These symptoms are typical and indicate that the body is strengthening its defenses.

Pfizer-BioNTech and Moderna are both mRNA vaccines and include material from the virus that causes COVID-19, which instructs human cells on how to manufacture a harmless protein that is unique to the virus. This material is not harmful. After making copies of the protein, our cells destroy the vaccine's genetic material. Our cells understand that the protein shouldn't be there and produce T- and B-lymphocytes that will remember how to fight the COVID-19 virus if we become infected again.

Vector vaccines such as the Johnson & Johnson vaccine include a modified form of a virus other than the one that causes COVID-19. A viral vector is material from the virus that causes COVID-19 inside the modified virus's casing.. Once the viral vector has entered our cells, the genetic material instructs the cells to produce a protein that is specific to the COVID-19 virus. Our cells create copies of the protein using these instructions. This causes our systems to produce T-lymphocytes and B-lymphocytes that remember how to fight the virus if we become infected again.

Booster doses improve or restore COVID-19 protection that has deteriorated over time. Everyone over the age of 12 who has completed the primary series of the COVID-19 vaccination should obtain a booster.

Here is the original post:

How do COVID-19 vaccines work? | City News - Red and Black

Germany may have to junk 3 million COVID-19 shots by late June – Los Angeles Times

April 12, 2022

BERLIN

Germanys health ministry said Monday that the country may have to discard 3 million doses of expired COVID-19 vaccine by the end of June.

Ministry spokesman Hanno Kautz told reporters in Berlin that not many doses have been destroyed so far, though he couldnt give an exact figure.

But Kautz said that we have more vaccine available at the moment than is being used and than we can donate. He added that COVAX, the U.N.-backed program to distribute shots to poorer countries, isnt currently accepting donations.

There is certainly a danger of vaccine being discarded, Kautz said. However, he added that it recently emerged that the BioNTech-Pfizer vaccine can be stored for longer than previously thought, so German officials now believe that 3 million doses may have to be discarded or destroyed by the end of June down from a previous estimate of 10 million.

Germanys vaccination program has slowed considerably, with an average of only 33,000 shots administered per day over the past week compared with over 1 million at times when the countrys booster campaign was in full swing in December.

Some 76% of the population has been fully vaccinated and 59% also have received a booster. Officials arent satisfied with the vaccination rate, particularly among older people, but the German parliament last week rejected a proposal to require all people 60 and over to get inoculated.

Visit link:

Germany may have to junk 3 million COVID-19 shots by late June - Los Angeles Times

Covid-19: Third death considered linked to vaccine was a teenager – Stuff

April 12, 2022

New Zealand's third death considered by safety monitoring officials to be linked to the Pfizer Covid-19 vaccine was a teenager.

On Monday evening, the Ministry of Health advised it had been notified of the tragic circumstance by the Covid-19 Vaccine Independent Safety Monitoring Board.

The teenager had myocarditis at the time of their death in December. However, there was not enough information at the time to determine the potential role of the vaccine.

Matt Rourke/AP

A third death considered to be linked to the Pfizer Covid-19 vaccine was a teenager, officials said.

Myocarditis inflammation of the heart muscle is a known, very rare side effect of the Pfizer vaccine. It can result from viral infections such as flu and puts about 100 Kiwis in hospital each year.

READ MORE:* Covid-19: Coroner investigating after autopsy links Dunedin man's death to 'very rare' side effect of Pfizer vaccine* Covid-19: Woman with medical issues dies from myocarditis, rare side-effect of Pfizer vaccine

Myocarditis has been estimated to affect about 30 per 1,000,000 vaccine recipients in New Zealand. It has largely been seen in males between 12-30 years of age after the second dose.

During Tuesday's press conference, the Director-General of Health Ashley Bloomfield advised that the young person, who had a dose of vaccine in the weeks prior to their death, was not experiencing any symptoms of myocarditis at the time of their quite sudden and very sad death.

The board considered the myocarditis was possibly due to vaccination. Its important to note the case is with the coroner, who is still investigating the cause of death.

ALDEN WILLIAMS/Stuff

To date, 4,005,406 Kiwis over the age of 12 have had two doses of Covid-19 vaccine.

Covid-19 is more likely to cause myocarditis than the vaccine almost four-times higher risk and the risk of Covid-19 far outweighs the risk of the vaccine.

More than eight of 10 reported cases have recovered quickly with rest and common medications, such as ibuprofen. Most reported cases have required hospital care for assessment and monitoring, because sudden death is a rare complication, the Immunisation Advisory Centre said, which is run out of the University of Auckland.

Bloomfield added the family were very clear" they didn't want the death to put people off from being vaccinated, or to be used by groups to undermine vaccine efforts in New Zealand.

More than four million Kiwis over the age of 12 have had two doses of Covid-19 vaccine.

Two previous deaths have been linked to the vaccine to date: a woman in her 50s and 26-year-old Rory Nairn, of Dunedin.

A new analysis of more than 11 studies, covering 395 million Covid-19 vaccine doses, published in the Lancet Respiratory Medicine on Monday found the very low risk of myopericarditis was comparable to or lower than the risk following non-Covid vaccinations.

Myocarditis is inflammation of the heart muscle, while pericarditis is inflammation of the tissue forming a sac around the heart. Myopericarditis means that both the heart muscle and the sac are inflamed.

It found the overall incidence of myopericarditis following Covid-19 vaccination was 18 cases per million, compared to 56 cases per million for non-Covid vaccines, such as influenza.

Symptoms of myocarditis or pericarditis linked to the vaccine generally appear within a few days, mostly within the first few weeks after vaccination, the Ministry of Health says.

If you get any of these new symptoms after vaccination, you should seek medical help, especially if they dont go away:

See the article here:

Covid-19: Third death considered linked to vaccine was a teenager - Stuff

Endemic: What it might mean for masks, COVID-19 shots and more – Scope

April 12, 2022

At this point in the pandemic, many of us are exhausted. Exhausted by two years of intermittent lockdowns, social distancing, remote learning and masking. Exhausted by the endless "if this, then that" mental gymnastics required of a simple trip to the grocery store or gathering with a group of friends.

The tantalizing possibility that the virus that causes COVID-19 could evolve to become endemic is the floating door from the Titanic on which we'd all like to ride back to normalcy. We're anxious to say goodbye to the iceberg that so utterly destroyed our pre-pandemic lives. We talk about "learning to live" with the virus, but what we really want is for it to fade seamlessly into the background of everyday life.

But what does endemic really mean, and will we actually get there? Will there ever be a day when we can ditch our masks for good and relegate COVID-19 caseload dashboards to our distant memories? Will we ever be able to get over the feelings of loss and -- let's face it -- anger caused by the past two years of disruption? Who needs vaccine boosters and how often?

I conferred with experts from around Stanford Medicine to discuss these and other questions.

Endemic is a multifaceted word. The Greek word demos means people, and endemios means native. The Merriam-Webster dictionary defines endemic as "belonging or native to a particular people or country" or something that is "restricted or particular to a locality or region." By that measure, pretty much anything can be defined as endemic: mullets sported by '80s American rock bands, heirloom Jell-O mold recipes passed down through generations of Midwestern church ladies, or fuzzy toques sported outdoors during Canadian winters.

But endemic means something more specific to biologists and clinicians. "When biologists talk about something being endemic, they are referring to a particular kind of relationship between different life forms," said David Relman, MD, the Thomas C. and Joan M. Merigan Professor, professor of microbiology and immunology, and a former president of the Infectious Diseases Society of America.

Many times, one of those life forms is a virus or bacteria that uses humans as its host. Like a lightning-sparked forest fire, the initial meeting between a pathogen and humans can be explosive. The disease-causing organism can race unchecked through a population while the human immune system struggles to catch up. Presto, an epidemic! But this kind of ongoing conflagration is not sustainable: The virus runs out of hosts to infect because they've all either become immune or died.

"In many cases, epidemic viruses fizzle out after a year or two if they are unsuccessful in establishing an endemic relationship with their host," Relman said. "Viruses want an opportunity to replicate and persist."

Clinically, an endemic relationship with SARS-CoV-2 is still tantalizingly beyond our grasp.

"If we are able to move beyond repeated, continuous surges into a time when COVID-19 is more seasonal, like the flu, it could be appropriate to call the virus endemic, meaning we can expect a certain amount of disease in a certain time or place in some predictable pattern," said Abraar Karan, MD, an infectious disease fellow at Stanford Medicine who has cared for many COVID-19 patients during the pandemic. "But I don't know when, in the next few years, this might happen. Right now, we have too many waves and variants coming back to back."

"It's difficult to know with confidence what endemicity might look like in the clinic," Relman agreed. "We may see seasonal epidemics, periodic asynchronous flares, or epidemics; or ongoing smoldering disease across the globe. But we are not there yet."

But what does endemic mean to the general public? To many, the term implies that we can relax our vigilance -- that COVID-19 is not a big deal anymore. After all, it's probably always going to be with us.

"The idea of a world with zero COVID-19 is really not possible anymore," Karan said. "The best we can hope for is to keep cases low and to prevent waves and surges."

Relman is cautiously hopeful that we are moving in the right direction. "I can't think of too many endemic microbes or viruses that, over time, have continued to cause the level of disruption that this virus has caused over the past two years," he said.

At this point, it seems that we're straddling a line between a pandemic and an endemic virus that will be with us forever: a kind of "pendemic," if you will. Recently the Centers for Disease Control and Prevention loosened isolation recommendations for infected people and relaxed many restrictions on indoor gatherings. This move means that decisions about precautionary measures, such as masking and avoiding crowds, are up to the individual. But relaxed restrictions are not the same as telling people, "You don't need a mask."

"Evidence suggests that now is an appropriate time to loosen mask mandates based on an individual's risk profile," said Ashley Styczynski, MD, MPH, an adjunct clinical assistant professor in infectious disease at Stanford who co-authored a large-scale study on the effect of masking on community transmission in Bangladesh. "But it's still too early to say there's no use for masks at all. Of all the things we can do to slow the spread of the virus, from masking to social distancing to stay-at-home orders, masks are the least restrictive intervention. I believe they will remain a critical part of our response as the virus continues to evolve."

N95s and KN95s are similar in terms of filtration efficiency, Styczynski said. (Surgical masks are slightly less efficient.) N95 masks, which usually have straps that fit over the back of the head rather than around the ears, have the tightest fit, giving them a protective advantage. But that also means they can be less comfortable than other types of masks. The elastic on N95s, KN95 and surgical masks can weaken after prolonged or repeated use, compromising the fit. Surgical masks have the loosest fit, but they have been shown to be more effective than cloth masks at preventing community transmission.

"A person who wants to limit transmission to themselves or others should choose a high-quality mask like an N95 or a KN95," Styczynski said. "For others, a surgical mask alone or under a cloth mask could be a good choice. The most effective mask, however, is the one that you will wear. So it's important to balance mask effectiveness and comfort."

Fit is important, but a mask that leaks a bit is more effective than no mask at all, Styczynski said. "You probably won't be wearing any of these masks perfectly. But a bit of air leakage doesn't mean the mask is pointless because not all viral particles are aerosolized. Surgical masks block droplets, for example. And all masks remind people not to touch their noses and mouths frequently."

To check the fit of your N95 or KN95 mask, Styczynski recommends taking a slow breath in while wearing your mask to check for leakage. "If the material of the mask slightly collapses when you inhale, you know your mask is filtering the air," she said. "When you breathe out, cup your hands around the outside of your mask to check for air leaks."

One of the most obvious, and difficult to manage, tolls of the past two years is the effect of the pandemic on our collective mental health. Many of us are experiencing a stew of emotions that can bounce from anxiety to frustration to sadness -- to flat-out anger at people with whom we disagree.

"Realizing that you can't control what other people are doing and that their actions could affect your life is basically a recipe for anxiety, and that can lead to friction and stress," said clinical psychiatrist Debra Kaysen, PhD, who specializes in the treatment of post-traumatic stress disorder and related conditions.

"We're in a period now where people have to figure out where their own personal comfort zones are, and act accordingly," said Kaysen. "And this can change day by day, according to the people and activities with which they engage."

This is tough for those of us (myself included) who just want to know what to do.

Kaysen recommends breaking down a situation (say, a crowded indoor wedding) into smaller questions: Will the attendees be vaccinated? Can I wear a mask? Then seek out reliable, science-based information about specific risks. If the process is too overwhelming, she suggests setting aside a specific amount of time to worry about things and then accepting the uncertainties and moving on. "Constant worry is never helpful, and it just makes you tired," she said.

Anger is also exhausting, and rarely productive, Kaysen said. "One of the most helpful things is to try to understand the other person's perspective, at least a little," she said. "The other is to avoid dehumanizing the other person, which we often do when we assign people to groups or categories. Empathy and compassion are important."

Kaysen gives an example: "I can understand that the lockdown was an economic hardship for business owners, and that must have been especially frustrating if case levels in their area were relatively low at the time. Or I can acknowledge that wearing masks and social distancing isn't fun, even though it may be necessary at times."

It can be difficult to feel your life is restricted while others appear to be living life as normal with seemingly no consequences.

"It's become necessary to practice an acceptance of uncertainty," Kaysen said. In general, humans are pretty bad at this. "It's particularly difficult for people prone to anxiety to accept that they cannot control outcomes, particularly around what they perceive as a threat. We want things to be black and white. Instead, we have many shades of gray that make up a constantly evolving picture."

There's more clarity around COVID-19 vaccines: It's been conclusively shown that vaccination saves lives.

"It's almost miraculous how well these vaccines work," said Yvonne Maldonado, MD, the Taube Professor in Global Health and Infectious Diseases. But the initial push to vaccinate all eligible Americans stumbled in the face of vaccine misinformation and hesitancy. And subsequent recommendations about booster shots have been fraught with confusion and frustration as the public tries to parse complicated scientific information almost in real time.

"The virus is mutating quickly, and this is a challenge to vaccine manufacturers," Michael Lin, MD, PhD, an associate professor of neurobiology and of bioengineering said. "We need to develop vaccines that remain effective in the face of new viral strains for longer than six months. We're not currently in that situation."

Lin's lab researches antiviral drugs to combat SARS-CoV-2 and he has been an active proponent on Twitter, and in the media, of the need to develop variant-specific boosters against the virus.

Recently, the Food and Drug Administration authorized -- and the CDC subsequently recommended -- a second booster shot to certain groups of people who received their first booster at least 4 to 6 months earlier. But many eligible people eager for another booster are left wondering whether to get one now, even though cases are relatively low, or to wait until promised omicron-specific boosters become available.

"It really depends on what happens with the evolution of the virus and the development of new vaccines," Lin said. "But it's quite possible we could get an additional level of protection from an annual booster every fall."

Still, the available vaccines and boosters, all of which target the original strain of the virus, drastically reduce the chance of becoming seriously ill or dying. And vaccine researchers and manufacturers are continuing to optimize their shots.

"We're going to get much better at building modular vaccines that can protect against more than one variant," Maldonado said. "We're also looking at traditional platforms used by vaccines like Novavax, which could be quickly adaptable to changing conditions. We couldn't do this initially because we were focused on learning whether the first vaccines were safe -- and they are incredibly safe. Now we're going to keep improving the technology to combat future variants and even other viruses."

Down the line, COVID-19 vaccine boosters could come in the form of a sniff, rather than a jab. Nasal-based vaccines target the "front door" of viral entry, revving up immune cells in the mucosa to barricade the door the moment the virus enters the nasal passages. "This could be the best way to quash infection and prevent transmission," Lin said.

Two years ago, we consoled ourselves with the idea that eventually we'd get back to a "new normal" in which we could comfortably cohabitate with the SARS-CoV-2 virus. Now, as the "pendemic" enters full-blown toddlerhood, we're realizing that uncertainty is a mainstay as we forge our own paths, lugging invisible abacuses bedecked with our individual risk and benefit beads and remembering what we left behind.

"There are still questions that no one can really answer with any degree of certainty," said Bali Pulendran, PhD, the Violetta L. Horton professor of pathology and microbiology and immunology. "But when historians look back at this time, there won't be any doubt about the devastating impact of this pandemic. We've seen 1 million deaths in this country. All of us have been through a war of sorts, a world war against this virus."

Read more the two-year mark of the beginning of the pandemic: Two years into the pandemic, medical scientists consider what the future may hold

Photo byDzmitry

Continued here:

Endemic: What it might mean for masks, COVID-19 shots and more - Scope

Federal COVID-19 Vaccination Directive Reinstated by Appeals Court – SHRM

April 10, 2022

A requirement for federal workers to be vaccinated against the coronavirus was recently upheld by a federal appeals court panel. The groups that challenged the vaccination directive, however, could ask the full appeals court or the U.S. Supreme Court to review the matter.

We've gathered articles on the news fromSHRM Onlineand other media outlets.

Pursuing Administrative Remedies

The vaccine requirementfor federal employees was put on hold after a district judge in Texas blocked the directive in January. In a 2-1 order on April 7, the 5th U.S. Circuit Court of Appeals reversed the district judge's ruling and dismissed the lawsuit against the vaccination directive. The appeals court said the district judge did not have jurisdiction in the case. Instead, the employees who challenged the requirement could have pursued administrative remedies through the Merit Systems Protection Board or Office of Special Counsel in accordance with the Civil Service Reform Act.

(AP News)

Directive Applies to Executive Branch Workers

Biden issued the executive order in September 2021 requiring vaccinations for all executive branch agency employees, unless they qualified for an exemption based on a medical or religious objection.

TheExecutive Order on Requiring Coronavirus Disease 2019 Vaccination for Federal Employeesapplies to employees of the executive branch of the federal government. Employees in the judicial and legislative branches are not covered by the order. The Safer Federal Workforce Taskforce has issuedguidanceon the vaccination requirement for federal agencies.

(Safer Federal Workforce Taskforce)

Most Covered Employees Vaccinated

Federal agencies had mostly not been enforcing the directive after the district court issued theinjunctionin Januarythough some agencies did continue to enforce their own vaccination requirements and process requests for medical and religious exemptions. At the time the injunction was issued, about 98 percent of federal employees were following the executive order and 93 percent of employees were vaccinated.

(Government Executive)

Supreme Court Nixed OSHA Directive for Private Employers

Other vaccination directives have also been challenged. The Occupational Safety and Health Administration(OSHA)withdrewits COVID-19 vaccination-or-testingEmergency Temporary Standard (ETS) in light ofa Supreme Court rulingthat halted the directive. The ETS would have applied to private-sector employers with at least 100 employees. However,the high court allowedthe Centers forMedicare& Medicaid Services (CMS) to proceed with a vaccinedirective that applies to health care workers at Medicare- and Medicaid-certified providers and suppliers.

(SHRM Online)

What to Do When Workers Refuse a COVID-19 Vaccination

Employers should note thateven though some federal directives have been blocked by courtsjudges have generallysided with the employerin lawsuits challenging a private company'svaccinationrequirements. Many businesses continue to review and revise their COVID-19 vaccination policies as the pandemicpersistsand employers may be asking what they can do if workers refuse to get the jab. Some employers are firing workers or putting them on unpaid leave. Others are requiring unvaccinated employees to submit to weekly testing and take other safety precautions.

(SHRM Online)

ManagingChanging COVID-19 Workplace Safety Obligations

Employers may be tempted to lift their pandemic-related safety requirements as federal and state authorities ease masking and other COVID-19 rules. But employers should note that they have ongoing obligations to protect the health and safety of their workers. Employment law attorneys recommend that employers designate a point person to provide periodic updates to their leadership team and work with experienced employment counsel to keep informed of any new safety rules. The point person should check the Centers for Disease Control and Prevention, OSHA and state health department websites for new guidelines and rules on a daily or weekly basis.

(SHRM Online)

More:

Federal COVID-19 Vaccination Directive Reinstated by Appeals Court - SHRM

No relationship between COVID-19 vaccines and AIDS | Ap | berkshireeagle.com – Berkshire Eagle

April 10, 2022

CLAIM: COVID-19 vaccines are causing a form of AIDS that is not related to HIV, long established as the cause of acquired immunodeficiency syndrome.

THE FACTS: There is no evidence that the COVID-19 vaccines cause any kind of immune deficiency condition, let alone AIDS, nor is there evidence that the COVID-19 vaccines damage the immune system, experts say. In a video circulating widely on social media, Dr. Robert Malone, a frequent critic of COVID-19 vaccines who once researched mRNA vaccine technology, made the claim that the vaccines are damaging T cell responses and causing a form of AIDS.

People think, when they hear AIDS, they hear HIV. No, the vaccines arent causing you to be infected with the HIV virus, said Malone, during a taped interview with a website that focuses on COVID-19. They are causing a form of acquired immunodeficiency syndrome, thats what AIDS stands for.

In the interview, published April 1, Malone claimed that lots of scientific data support his claim, but cited no evidence. The claims are unfounded. As The Associated Press previously reported, there is no evidence that COVID-19 vaccines damage the immune system or cause AIDS, and there is also no evidence that the vaccines are causing a form of AIDS that doesnt stem from HIV, experts tell the AP. John Swartzberg, a clinical professor of infectious diseases and vaccinology at the University of California, Berkeley, said he knows of no data showing that mRNA vaccines cause immunodeficiency of any kind, including AIDS.

What is widely accepted is that vaccines, including COVID-19 vaccines, cause short-term immune activation, not deficiency, Richard E. Chaisson, the director of the Johns Hopkins Center for AIDS Research, wrote in an email. Dr. Malone is distorting and misrepresenting data.

The AP has previously reported on false claims that COVID-19 vaccines damage T cells. Research shows the vaccines boost the immune response. HIV attacks the bodys immune system, according to the Centers for Disease Control and Prevention. It is often spread through sexual contact, shared or contaminated needles and infected blood. If untreated, it can lead to AIDS. Both Chaisson and Swartzberg wrote that the term AIDS is strictly used to describe the condition caused by HIV. Chaisson described Malones use of the term as deliberately provocative and irresponsible. There are forms of inherited immunodeficiency, such as severe combined immunodeficiency, that result in life-threatening infections, Chaisson noted. But, he said, there is no evidence that these conditions are caused by COVID-19 vaccines. Malone did not respond to a request for comment.

Associated Press writer Josh Kelety in Phoenix contributed this report.

Read the rest here:

No relationship between COVID-19 vaccines and AIDS | Ap | berkshireeagle.com - Berkshire Eagle

Column: For two years, I’ve tried to protect myself from COVID-19. Now I’ve tested positive – Los Angeles Times

April 10, 2022

I was supposed to be getting my second vaccine booster this week. Instead, I failed a COVID test.

I tested because my daughter, a teacher, had a positive test and Id spent time with her. Still, I was dumbstruck by my positive result.

My daughter wound up coughing and aching and couldnt smell the candle she loves, but I have yet to experience a single symptom. In fact, with all the vitamin-taking and oxygen-monitoring and resting Ive done while I quarantine, I feel healthier than Ive felt in months.

When a few days passed, with no signs of illness, the skeptic in me figured the test I took must be wrong. But the doctor I spoke with ruled that out. Its a highly reliable rapid test that detects genetic material from the virus at exquisitely low levels, he said.

Its almost embarrassing to finally confront the demon Ive feared for two years and find that the version afflicting me packs a punch I cannot even feel. Im apparently among the 30% to 40% of people with the coronavirus whose infections are so mild, they are asymptomatic.

I would like to take some credit for that: Im vaxxed and boosted and still masking around strangers and indoors in public places.

But the truth is that while we know that vaccinations blunt the severity of the disease, we dont yet fully understand why some infected people have no symptoms at all, while others wind up hospitalized and so many die. And no one can say whether long-haul COVID-19 difficulties await asymptomatic people down the line.

I know all this because I have spent my quarantine holed up in my bedroom, panic-Googling, trying to figure out what is going to happen to my asthmatic, senior-citizen self.

In the process, I stopped feeling odd and began to feel uncommonly lucky. Somehow a global disease that has killed more than 6 million people, and is still causing untold suffering, had spared me the worst of its misery.

During the past few months Ive felt increasingly safe, as infections declined and Los Angeles Countys COVID-19 hospitalizations plunged from 4,800 to less than 300.

But I knew that a few days of symptom-free infection didnt guarantee I was out of the woods. It can take as long as two weeks after exposure for debilitating symptoms of COVID-19 to emerge. And that knowledge has made every allergy-related sneeze feel like it could be a death knell.

But six days in, two separate tests have found no more virus in my system.

That is not surprising, according to Dr. George Rutherford, an epidemiologist at UC San Francisco and one of Californias foremost COVID-19 experts. He says people with asymptomatic infections dont necessarily have less virus in their bodies, but they may be able to clear the virus more efficiently.

We were doing a lot of contact tracing in the early days, Rutherford recalled. Thats when the virus had a longer incubation period, and we could get to people before they were infectious so they would not unknowingly infect others.

Now that the disease can incubate in three days, we just have to throw up our hands and look for new ways to stop asymptomatic spread, Rutherford said.

Im grateful to be in the asymptomatic category. But a positive test result still carries a taint; like a scarlet letter declaring to the world that you have done something wrong.

Perhaps I failed to pay enough attention to the rise of the supercontagious BA.2 Omicron subvariant.

Im certified negative now, but Im following CDC guidelines: quarantining at home and wearing a mask every time I leave my room. Still, its hard to have full confidence in the rules any more when they cant necessarily keep up with the virus evolution.

Dont get me wrong. I will resume masking in public when my home confinement ends. But I will also stop expecting this pandemic to ease anytime soon. Many asymptomatic people wont know they have the virus and move through their days unmasked.

Im going to stop obsessing over fluctuating COVID rates and new, more infectious varieties. Ill stop poring over the numbers which told me that people my age are the least likely to be asymptomatic. And Im going to start taking better care of myself, day in and day out.

What this past week has taught me is that we are just pretending to understand this virulent, mysterious and unpredictable pandemic.

We bury ourselves in statistics, as if that gives us a sense of control. But what does the case count even mean now that so many folks are testing themselves at home and no one is tallying those results?

I appreciate all the work the researchers are doing. Rutherford said there are now tantalizing hints that blood type may be linked to COVID-19 immunity. That kind of revelation might lead to new ways to prevent or treat the disease. But even a perfect understanding of the big picture wont mean we can predict the course of an individual infection.

From a public health standpoint, were not worried about you. ... Youre a good outcome, Rutherford said. Not as good as having no infection. But having an asymptomatic infection, well chalk that up as a win.

And right now, that sounds pretty good to me.

Go here to read the rest:

Column: For two years, I've tried to protect myself from COVID-19. Now I've tested positive - Los Angeles Times

Page 257«..1020..256257258259..270280..»